IL82400A0 - Production of m-csf - Google Patents

Production of m-csf

Info

Publication number
IL82400A0
IL82400A0 IL82400A IL8240087A IL82400A0 IL 82400 A0 IL82400 A0 IL 82400A0 IL 82400 A IL82400 A IL 82400A IL 8240087 A IL8240087 A IL 8240087A IL 82400 A0 IL82400 A0 IL 82400A0
Authority
IL
Israel
Prior art keywords
production
csf
polypeptides
methods
provided via
Prior art date
Application number
IL82400A
Other languages
English (en)
Original Assignee
Genetics Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/860,377 external-priority patent/US4879227A/en
Priority claimed from US06/940,362 external-priority patent/US4868119A/en
Application filed by Genetics Inst filed Critical Genetics Inst
Publication of IL82400A0 publication Critical patent/IL82400A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Prostheses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL82400A 1986-05-06 1987-05-01 Production of m-csf IL82400A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/860,377 US4879227A (en) 1986-05-06 1986-05-06 Production of a recombinant human colony stimulating factor
US06/940,362 US4868119A (en) 1986-12-11 1986-12-11 Hematopoietic growth factors

Publications (1)

Publication Number Publication Date
IL82400A0 true IL82400A0 (en) 1987-11-30

Family

ID=27127565

Family Applications (1)

Application Number Title Priority Date Filing Date
IL82400A IL82400A0 (en) 1986-05-06 1987-05-01 Production of m-csf

Country Status (21)

Country Link
US (1) US5573763A (es)
EP (1) EP0307402B1 (es)
JP (2) JP2579981B2 (es)
KR (1) KR960004453B1 (es)
AT (1) ATE92966T1 (es)
AU (1) AU606056B2 (es)
CA (1) CA1334942C (es)
DE (1) DE3787020T2 (es)
DK (1) DK2688A (es)
ES (1) ES2007341A6 (es)
FI (1) FI884877A (es)
GR (1) GR870688B (es)
HU (1) HU212277B (es)
IE (1) IE60835B1 (es)
IL (1) IL82400A0 (es)
MX (1) MX9203130A (es)
MY (1) MY101209A (es)
NO (1) NO880022L (es)
OA (1) OA09112A (es)
PH (1) PH24301A (es)
WO (1) WO1987006954A1 (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847201A (en) * 1985-02-05 1989-07-11 Cetus Corporation DNA encoding for CSF-1 and accompanying recombinant systems
US5556620A (en) * 1985-02-05 1996-09-17 Cetus Oncology Corporation Use of recombinant colony stimulating factor-1 to enhance wound healing
US6117422A (en) * 1985-02-05 2000-09-12 Chiron Corporation N∇2-CSF-1(long form) and carboxy truncated fragments thereof
US5422105A (en) * 1985-02-05 1995-06-06 Cetus Oncology Corporation Use of recombinant colony stimulating factor 1
WO1986004607A1 (en) * 1985-02-05 1986-08-14 Cetus Corporation Recombinant colony stimulating factor-1
US5104650A (en) * 1985-02-05 1992-04-14 Cetus Corporation Uses of recombinant colony stimulating factor-1
US6156300A (en) * 1985-02-05 2000-12-05 Chiron Corporation Point mutants of N∇2 CSF-1 and carboxy truncated fragments thereof
US5573930A (en) 1985-02-05 1996-11-12 Cetus Oncology Corporation DNA encoding various forms of colony stimulating factor-1
US5837229A (en) * 1985-02-05 1998-11-17 Chiron Corporation Uses of recombinant colony stimulating factor-1
US4808611A (en) * 1986-07-30 1989-02-28 Immunex Corporation Use of interleukin-1 to induce development of multipotent hemopoietic cell populations
US5650297A (en) * 1986-09-17 1997-07-22 Otsuka Pharmaceutical Co., Ltd. DNA encoding human colony-stimulating factors
JP2583829B2 (ja) * 1986-09-17 1997-02-19 大塚製薬株式会社 ヒトｍ−ｃｓｆ
JP2583770B2 (ja) * 1986-09-17 1997-02-19 大塚製薬株式会社 遺伝子
JPH07100720B2 (ja) * 1987-07-17 1995-11-01 森永乳業株式会社 コロニー刺激因子の製造法
IL86090A (en) * 1987-04-16 1993-03-15 Cetus Oncology Corp Production of purified, biologically active, bacterially produced recombinant human csf-1
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1
CA1339757C (en) * 1987-04-16 1998-03-17 Robert F. Halenbeck Production of purified biologically active, bacterially produced recombinant human csf-1
EP0379522B1 (en) * 1987-09-22 1995-05-03 Cetus Oncology Corporation Uses of recombinant colony stimulating factor-1
US5260421A (en) * 1987-12-21 1993-11-09 Applied Research Systems Ars Holding N.V. Site-directed mutagenesis modified glycoprotein hormones
US4847325A (en) * 1988-01-20 1989-07-11 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
DK54589A (da) * 1988-02-08 1989-08-09 Otsuka Pharma Co Ltd Humane kolonistmulerende faktorer
JPH0610137B2 (ja) * 1988-02-29 1994-02-09 新技術事業団 ヒト単球−マクロファージコロニー刺激因子を有効成分とする造血器疾患治療剤
WO1989010158A1 (en) * 1988-04-27 1989-11-02 Immunomedics, Inc. Improved radiotherapy
US5888495A (en) * 1988-05-23 1999-03-30 Genetics Institute, Inc. Method of producing storage stable M-CSF lyophilizates
US5171675A (en) * 1988-07-28 1992-12-15 Cerretti Douglas P Macrophage colony stimulating factor-γ
WO1990008554A1 (en) * 1989-01-30 1990-08-09 Schering Corporation Treatment of leukocyte dysfunction with gm-csf
WO1990009400A1 (en) * 1989-02-10 1990-08-23 Cetus Corporation M-csf monoclonal antibodies that recognize a neutralizing conformational epitope
AU625081B2 (en) * 1989-02-28 1992-07-02 Morinaga Milk Industry Company Limited Human monocyte-macrophage-csf preparations
US5288487A (en) * 1989-02-28 1994-02-22 Morinaga Milk Industry Co., Ltd. Human monocyte-macrophage-CSF preparations
WO1990012877A1 (en) * 1989-04-19 1990-11-01 Cetus Corporation Multifunctional m-csf proteins and genes encoding therefor
EP0410751B1 (en) * 1989-07-27 1996-04-10 Denki Kagaku Kogyo Kabushiki Kaisha Gene encoding M-CSF and related recombinant systems thereof
AU6125294A (en) * 1993-01-13 1994-08-15 Genetics Institute Inc. Process for producing m-csf 223
WO1997038087A2 (en) 1996-04-05 1997-10-16 Chiron Corporation Alphaviral vector with reduced inhibition of cellular macromolecular synthesis
US6455678B1 (en) * 1996-04-26 2002-09-24 Amcell Corporation Human hematopoietic stem and progenitor cell antigen
CA2260014A1 (en) * 1996-07-10 1998-01-15 Meiji Milk Products Co., Ltd. Novel use of mk family as hematopoietic factor
EP1117384A1 (en) * 1998-10-01 2001-07-25 Elan Pharma International Limited Controlled release nanoparticulate compositions
US7108852B2 (en) 2000-03-20 2006-09-19 Warner-Lambert Company Llc Methods of treating inflammation using antibodies to M-CSF
AR045563A1 (es) 2003-09-10 2005-11-02 Warner Lambert Co Anticuerpos dirigidos a m-csf
WO2008060610A2 (en) * 2006-11-17 2008-05-22 Biogen Idec Ma Inc. Systemic administration of colony stimulating factors to treat amyloid associated disorders
EP4309666A1 (en) 2022-07-21 2024-01-24 Technische Universität Dresden M-csf for use in the prophylaxis and/or treatment of viral infections in states of immunosuppression
WO2024017998A1 (en) 2022-07-21 2024-01-25 Technische Universität Dresden M-csf for use in the prophylaxis and/or treatment of viral infections in states of immunosuppression

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784949A (en) * 1984-04-19 1988-11-15 Cetus Corporation Universal dominant selectable marker cassette
WO1986004607A1 (en) * 1985-02-05 1986-08-14 Cetus Corporation Recombinant colony stimulating factor-1
DE3686794T2 (de) * 1985-02-05 1993-03-04 Cetus Oncology Corp Reinigung des natuerlichen kolonie-stimulierenden faktors-1.
US4847201A (en) * 1985-02-05 1989-07-11 Cetus Corporation DNA encoding for CSF-1 and accompanying recombinant systems
JP2583770B2 (ja) * 1986-09-17 1997-02-19 大塚製薬株式会社 遺伝子
WO1988003173A2 (en) * 1986-10-24 1988-05-05 Cetus Corporation New forms of colony stimulating factor-1

Also Published As

Publication number Publication date
HU212277B (en) 1996-04-29
NO880022D0 (no) 1988-01-05
EP0307402A4 (en) 1990-02-22
HUT47979A (en) 1989-04-28
AU606056B2 (en) 1991-01-31
WO1987006954A1 (en) 1987-11-19
EP0307402B1 (en) 1993-08-11
JPH01502397A (ja) 1989-08-24
EP0307402A1 (en) 1989-03-22
JPH07147989A (ja) 1995-06-13
CA1334942C (en) 1995-03-28
AU7289087A (en) 1987-12-01
MY101209A (en) 1991-08-17
MX9203130A (es) 1992-07-01
FI884877A0 (fi) 1988-10-21
DK2688A (da) 1988-03-07
FI884877A (fi) 1988-10-21
PH24301A (en) 1990-05-29
KR960004453B1 (en) 1996-04-06
GR870688B (en) 1987-09-07
OA09112A (en) 1991-10-31
JP2579981B2 (ja) 1997-02-12
IE60835B1 (en) 1994-08-24
ES2007341A6 (es) 1989-06-16
DE3787020T2 (de) 1993-12-16
ATE92966T1 (de) 1993-08-15
DE3787020D1 (de) 1993-09-16
KR880701288A (ko) 1988-07-26
US5573763A (en) 1996-11-12
DK2688D0 (da) 1988-01-05
IE870994L (en) 1987-11-06
NO880022L (no) 1988-01-05

Similar Documents

Publication Publication Date Title
KR960004453B1 (en) Production of m-csf
NZ221046A (en) Interleukin-3 and interleukin-3 like polypeptides from primates, pharmaceutical compositions and recombinant methods for producing the polypeptides
ES8602361A1 (es) Procedimiento para preparar una composicion pulverulenta para bebida
ES8800272A1 (es) Un procedimiento para la preparacion de polipeptidos.
NO860758L (es)
PT77370A (en) Process for preparing new pyrazolo <3,4-b> piridine derivatives and pharmaceutical preparations containing the same
GB8729542D0 (en) Upper part of two-part piston for i c engines & process for production thereof
GR3003638T3 (es)
ES8203371A1 (es) Procedimiento de preparar indolo(2,3,3,4)pirido(2,1-b)quina-zolin-5-onas
ES8609301A1 (es) Procedimiento para la obtencion de 3-metil-7-fluor-5-nitro- benzotiofeno
MY100528A (en) Alpha adrenergic amine of substantial alpha amine activity as an antiperspirant.
EP0071919A3 (en) Spiro(benzofuran-2(3h),4'(2'h)-isoquinoline)s, a process for their preparation and their use as medicaments
HUT44164A (en) Composition for hygieny of mouth and process for production thereof
GB8616516D0 (en) Production of polypeptide
ES8606375A1 (es) Un procedimiento para preparar un derivado de aminoprpilaminobleomicina
ZA874796B (en) Novel family of primate hematopoietic growth factors
IE860615L (en) Production of interleukin-2

Legal Events

Date Code Title Description
RH Patent void